Lakeshore Biopharma Co. Ltd (LSBCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2021 | 03-2021 | |
| Operating Expenses | 44 | 0 |
| Operating Income | -44 | N/A |
| Other Income | -4,637 | 0 |
| Pre-tax Income | -4,681 | 0 |
| Net Income Continuous | -4,681 | N/A |
| Net Income | $-4,681 | $N/A |
| EPS Basic Total Ops | -4.60 | N/A |
| EPS Basic Continuous Ops | -8.14 | N/A |
| EPS Diluted Total Ops | -4.60 | N/A |
| EPS Diluted Continuous Ops | -8.14 | N/A |
| EBITDA(a) | $-44 | $N/A |